logo
  

EARNINGS SUMMARY: Details of Array BioPharma Inc. Q1 Earnings Report

Below are the earnings highlights for Array BioPharma Inc. (ARRY):

-Earnings: -$20.99 million in Q1 vs. -$27.59 million in the same period last year.
-EPS: -$0.15 in Q1 vs. -$0.21 in the same period last year.
-Analysts projected -$0.18 per share
-Revenue: $16.20 million in Q1 vs. $6.07 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Inflation data from the U.S. garnered maximum attention this week on the economics front, along with the interest rate decision by the European Central Bank. Read our stories to find out how these two key events are set to influence monetary policy in the months ahead. Other main news from the U.S. were the release of the minutes of the latest Fed policy session and the jobless claims data. Elsewhere, the interest rate decision by the Bank of Canada was also in focus.

View More Videos
Follow RTT